ABBVIE
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 Drug Manufacturers - General
業務概覽 AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan addedseveral new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
公司地址 1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
電話號碼 +1 847 932-7900
傳真號碼 --
公司網頁 https://www.abbvie.com
員工數量 57000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. David R. Purdue Principal Accounting Officer, Senior Vice President and Controller -- 20/02/2026
Mr. Demetris D. Crum Executive Vice President and Chief Human Resources Officer -- 20/02/2026
Dr. Roopal Thakkar, M.D. Executive Vice President, Research and Development and Chief Scientific Officer -- 20/02/2026
Dr. Azita Saleki-Gerhardt, B.S.,M.S.,PhD Executive Vice President and Chief Operations Officer 美元 1.02M 20/02/2026
Dr. Nicholas J. Donoghoe, M.D. Executive Vice President, Chief Business and Strategy Officer -- 20/02/2026
Mr. Robert A. Michael Chairman of the Board and Chief Executive Officer 美元 1.61M 20/02/2026
Mr. Jeffrey Ryan Stewart Executive Vice President and Chief Commercial Officer 美元 1.28M 20/02/2026
Mr. Scott T. Reents Executive Vice President and Chief Financial Officer 美元 1.07M 20/02/2026
Mr. Perry C. Siatis Executive Vice President, General Counsel and Secretary -- 20/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Frederick H. Waddell Independent Director 20/02/2026
Ms. Rebecca B. Roberts Independent Director 20/02/2026
Dr. Robert J. Alpern,M.D. Independent Director 20/02/2026
Mr. Thomas C. Freyman Independent Director 20/02/2026
Mr. Edward J. Rapp Independent Director 20/02/2026
Dr. Susan E. Quaggin, M.D. Independent Director 20/02/2026
Ms. Roxanne S. Austin Lead Independent Director 20/02/2026
Mr. Brett J. Hart Independent Director 20/02/2026
Mr. William H.L. Burnside Independent Director 20/02/2026
Ms. Melody B. Meyer Independent Director 20/02/2026
Mr. Robert A. Michael Chairman of the Board and Chief Executive Officer 20/02/2026
Mr. Thomas J. Falk Independent Director 20/02/2026
Ms. Jennifer L. Davis Independent Director 20/02/2026
 
所屬ETF (更新日期: 07/03/2026 04:13)
代號 名稱 佔比% ▼ 持有日期
RSPEInvesco ESG S&P 500 Equal Weight ETF0.0001%27/02/2026
VUSVirtus U.S. Dividend ETF0.0001%27/02/2026
PEPSParametric Equity Plus ETF0.0001%27/02/2026
HEQQJPMorgan Nasdaq Hdg Eq Ldrd Overlay ETF0.0001%27/02/2026
BRCEMFS Blended Research Core Equity ETF0.0001%27/02/2026
FBUFFidelity Dynamic Buffered Equity ETF0.0001%27/02/2026
LCDSJPMorgan Fundamental Data Sci Lg Cor ETF0.0001%27/02/2026
AVIEAvantis Inflation Focused Equity ETF0.0001%28/02/2026
JDIVJPMorgan Dividend Leaders ETF0.00005%27/02/2026
RNDFirst Trust Bloomberg R&D Leaders ETF0.00005%26/02/2026
QRFTQRAFT AI-Enhanced US Large Cap ETF0.00004%27/02/2026
ANEWProShares MSCI Trnsfmtnl Chngs ETF0.00004%27/02/2026
NBGXNeuberger Growth ETF0.00004%28/02/2026
ACGRAmerican Century Large Cap Growth ETF0.00004%31/12/2025
FEACFidelity Enhanced U.S. All-Cap Eq ETF0.00003%27/02/2026
ABOTAbacus FCF Innovation Leaders ETF0.00003%27/02/2026
JFLIJPMorgan Flexible Income ETF0.00003%27/02/2026
MPLYMonopoly ETF0.00003%27/02/2026
ALRGAllspring LT Large Core ETF0.00003%28/02/2026
DEUSXtrackers Russell US Multifactor ETF0.00003%26/02/2026
  1    2    3    4    5    6    7    8    9    10    11    12    13    14    15    16    17   18    19    20    21    22    23    24    25  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.